SCHEMBL1494534

SCHEMBL1494534

CC(CNc1nccc(-c2c(Br)nc(C3CC3)n2COCC[Si](C)(C)C)n1)NC(=O)O

nearest known ligand 0.37

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BRAF P15056 20/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1494703 0.97 BRAF (0.36) BRAF
SCHEMBL6524460 0.93 BRAF (0.43) BRAF
SCHEMBL6524462 0.93 BRAF (0.43) BRAF
SCHEMBL6521889 0.90 BRAF (0.38) BRAF
SCHEMBL6521886 0.90 BRAF (0.38) BRAF
SCHEMBL6524588 0.89 DGAT1 (0.33) BRAF
SCHEMBL6526432 0.88 BRAF (0.36) BRAF
SCHEMBL6526429 0.88 BRAF (0.36) BRAF
SCHEMBL6524581 0.86 DGAT1 (0.32)
SCHEMBL6524591 0.86 DGAT1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2470528-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS Novartis AG (CH) 2012-07-04 EP disclosed
WO-2011023773-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS NOVARTIS AG (CH) 2011-03-03 WO disclosed